Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Evotec SE (EVO) EBT Margin (2019 - 2025)

Historic EBT Margin for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to 26.21%.

  • Evotec SE's EBT Margin fell 8600.0% to 26.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.35%, marking a year-over-year increase of 69220200.0%. This contributed to the annual value of 24.34% for FY2024, which is 140300.0% down from last year.
  • Latest data reveals that Evotec SE reported EBT Margin of 26.21% as of Q3 2025, which was down 8600.0% from 24.33% recorded in Q4 2024.
  • Over the past 5 years, Evotec SE's EBT Margin peaked at 54929.35% during Q4 2021, and registered a low of 30169.5% during Q4 2022.
  • Moreover, its 5-year median value for EBT Margin was 13.07% (2022), whereas its average is 679.97%.
  • In the last 5 years, Evotec SE's EBT Margin plummeted by 2000000000bps in 2021 and then surged by 162866100bps in 2023.
  • Evotec SE's EBT Margin (Quarter) stood at 54929.35% in 2021, then plummeted by -155bps to 30169.5% in 2022, then soared by 54bps to 13882.89% in 2023, then soared by 100bps to 24.33% in 2024, then decreased by -8bps to 26.21% in 2025.
  • Its EBT Margin stands at 26.21% for Q3 2025, versus 24.33% for Q4 2024 and 25.35% for Q3 2024.